Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to voluntarily sign a written consent form agreeing to take part in the study.
- People who are male or female, aged between 18 and 65 years old.
- People who have been diagnosed with acute lymphoblastic leukemia (a type of blood cancer) according to World Health Organization standards.
- People whose leukemia has gone into full remission (meaning no signs of active leukemia in the blood) before the transplant takes place.
- People who have a matching brother or sister available to donate stem cells, and who consent to receiving a stem cell transplant from that sibling donor.
- People who are generally able to care for themselves and carry out normal daily activities, as measured by a standard health performance scale (score of 70 or higher out of 100).
- People whose heart, liver, kidney, and lung function all fall within acceptable ranges as determined by specific medical tests (confirm exact values with the trial site).
- Women who could become pregnant must have a negative pregnancy test at the start of the study and must agree to use effective contraception for at least one year after the transplant.
- Male participants whose partners could become pregnant must agree to use effective barrier contraception and not donate sperm for at least one year after the transplant.
Who may not be able to join:
- People whose leukemia has not gone into full remission before the planned transplant.
- People who have chosen a stem cell donor who is not a matched sibling.
- People with serious heart, liver, kidney, or lung disease that would make it unsafe to go through the pre-transplant treatment process.
- People who have an active infection that is not responding to treatment, or other serious life-threatening complications.
- People who have a history of another type of cancer, a psychiatric disorder, or HIV infection.
- People who are unwilling to sign the consent form, unable to attend the required follow-up visits, or do not agree to allow their data to be used to support future research and medical practice.
- People whom the trial investigators consider unsuitable for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86037166862278
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Relapse-free survival (RFS); acute Graft Versus Host Disease (aGVHD); Overall Survival (OS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.